Related references
Note: Only part of the references are listed.Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer
L. B. Van Rijssen et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy
Shlomit Strulov Shachar et al.
CLINICAL CANCER RESEARCH (2017)
Inadequacy of Body Weight-Based Recommendations for Individual Protein Intake-Lessons from Body Composition Analysis
Corinna Geisler et al.
NUTRIENTS (2017)
Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy
Michael P. Chu et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer
David P. J. van Dijk et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
Valentine Heidelberger et al.
INVESTIGATIONAL NEW DRUGS (2017)
Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer
Dong-Dong Huang et al.
SURGERY (2017)
Evaluation of resistance training to improve muscular strength and body composition in cancer patients undergoing neoadjuvant and adjuvant therapy: a meta-analysis
Camila S. Padilha et al.
JOURNAL OF CANCER SURVIVORSHIP (2017)
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
Tora S. Solheim et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Psoas as a sentinel muscle for sarcopenia: a flawed premise
Vickie E. Baracos
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer
Carolina Palmela et al.
JOURNAL OF GASTRIC CANCER (2017)
Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients
Johanna Nattenmueller et al.
PLOS ONE (2017)
Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer
Alaa A. Almasud et al.
PLOS ONE (2017)
Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract
Jeroen L. A. van Vugt et al.
PLOS ONE (2017)
Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study
Elizabeth M. Cespedes Feliciano et al.
CANCER (2017)
Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer
Jessie A. Elliott et al.
ANNALS OF SURGERY (2017)
Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer
Shinya Okumura et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
ESPEN expert group recommendations for action against cancer-related malnutrition
J. Arends et al.
CLINICAL NUTRITION (2017)
Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer
Tateaki Naito et al.
BMC CANCER (2017)
Prediction of 90 Day and Overall Survival after Chemoradiotherapy for Lung Cancer: Role of Performance Status and Body Composition
J. C. S. Bowden et al.
CLINICAL ONCOLOGY (2017)
Body Composition as a Predictor of Toxicity in Patients Receiving Anthracycline and Taxane-Based Chemotherapy for Early-Stage Breast Cancer
Shlomit Strulov Shachar et al.
CLINICAL CANCER RESEARCH (2017)
Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study)
Bette J. Caan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer
Kensuke Kudou et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell Carcinoma
Edouard Auclin et al.
CLINICAL GENITOURINARY CANCER (2017)
The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
Louise E. Daly et al.
BRITISH JOURNAL OF CANCER (2017)
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer
Bjorg Sjoblom et al.
CLINICAL LUNG CANCER (2017)
Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study
N. Lou et al.
EJSO (2017)
Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib
Samantha J. Cushen et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
ESPEN guidelines on nutrition in cancer patients
Jann Arends et al.
CLINICAL NUTRITION (2017)
Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy
Hanah N. Rier et al.
BREAST (2017)
Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma
K. Harada et al.
DISEASES OF THE ESOPHAGUS (2016)
Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer
Dietmar Tamandl et al.
EUROPEAN RADIOLOGY (2016)
Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy
Yasunari Fukuda et al.
GASTRIC CANCER (2016)
Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer
Naomi Hayashi et al.
ONCOLOGY REPORTS (2016)
Low Muscularity and Myosteatosis Is Related to the Host Systemic Inflammatory Response in Patients Undergoing Surgery for Colorectal Cancer
George Malietzis et al.
ANNALS OF SURGERY (2016)
Impact of Sarcopenic Obesity on Surgical Site Infection after Laparoscopic Total Gastrectomy
Tatsuto Nishigori et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer
Stephanie Chemama et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial
Scott C. Adams et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Influence of body composition profile on outcomes following colorectal cancer surgery
G. Malietzis et al.
BRITISH JOURNAL OF SURGERY (2016)
Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients
Poorna Anandavadivelan et al.
CLINICAL NUTRITION (2016)
Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer
Bjorg Sjoblom et al.
CLINICAL NUTRITION (2016)
Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer
C. C. Margadant et al.
EJSO (2016)
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
Shlomit Strulov Shachar et al.
EUROPEAN JOURNAL OF CANCER (2016)
Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer
Amanika Kumar et al.
GYNECOLOGIC ONCOLOGY (2016)
Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer
B. C. Boer et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2016)
Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer
Susanne Blauwhoff-Buskermolen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Sarcopenia as a Predictor of Pulmonary Complications After Esophagectomy for Thoracic Esophageal Cancer
Tatsuto Nishigori et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma
Hiroshi Fukushima et al.
JOURNAL OF UROLOGY (2016)
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
Jennifer S. Temel et al.
LANCET ONCOLOGY (2016)
Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact
C. M. Prado et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2016)
Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later
Aoife M. Ryan et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2016)
Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes
Seyyed Mohammad Reza Kazemi-Bajestani et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)
Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer
Brechtje A. Grotenhuis et al.
WORLD JOURNAL OF SURGERY (2016)
Clinical Implications of Sarcopenic Obesity in Cancer
Isabella P. Carneiro et al.
CURRENT ONCOLOGY REPORTS (2016)
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens
Raafi Ali et al.
CANCER MEDICINE (2016)
Effects of rehabilitation among patients with advances cancer: a systematic review
Minna R. J. Salakari et al.
ACTA ONCOLOGICA (2015)
Functional Compromise Reflected by Sarcopenia, Frailty, and Nutritional Depletion Predicts Adverse Postoperative Outcome After Colorectal Cancer Surgery
Kostan W. Reisinger et al.
ANNALS OF SURGERY (2015)
Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma
Thibault Voron et al.
ANNALS OF SURGERY (2015)
Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer
Yuji Miyamoto et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery
Kostan W. Reisinger et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer
Satoshi Ida et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer
Jeroen L. A. van Vugt et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer
B. H. L. Tan et al.
EJSO (2015)
The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: a systematic review
D. J. Gibson et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2015)
Effect of Low-Intensity Physical Activity and Moderate-to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial
Hanna van Waart et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia
Neda Amini et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2015)
Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma
Stef Levolger et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Sarcopenia Is Highly Prevalent in Patients Undergoing Surgery for Gastric Cancer But Not Associated With Worse Outcomes
Juul J. W. Tegels et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer
Eun Young Kim et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer
Bjorg Sjoblom et al.
LUNG CANCER (2015)
Comparing Two Classifications of Cancer Cachexia and Their Association with Survival in Patients with Unresected Pancreatic Cancer
Nima Wesseltoft-Rao et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer
Oscar Arrieta et al.
ONCOLOGIST (2015)
Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia
Steven B. Heymsfield et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2015)
Prognostic Significance of Muscle Attenuation in Pancreatic Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
Takahiro Akahori et al.
WORLD JOURNAL OF SURGERY (2015)
Sarcopenia as a predictor of complications in penile cancer patients undergoing inguinal lymph node dissection
Pranav Sharma et al.
WORLD JOURNAL OF UROLOGY (2015)
Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma
Robert J. S. Coelen et al.
HPB (2015)
Exercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic review
Antonio Jose Grande et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
Frederick Moryoussef et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2015)
Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer
Amanda B. Cooper et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma
Soichi Iritani et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Sarcopenia Is an Independent Predictor of Complications Following Pancreatectomy for Adenocarcinoma
Savita Joglekar et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Sarcopenia as a Prognostic Biomarker of Advanced Urothelial Carcinoma
Hiroshi Fukushima et al.
PLOS ONE (2015)
Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer
Yuji Miyamoto et al.
PLOS ONE (2015)
Skeletal Muscle Density Is Independently Prognostic of Outcomes in Newly Diagnosed Mantle Cell Lymphoma Patients: Post Hoc Analysis of LYM 3002
Michael P. Chu et al.
BLOOD (2015)
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
Stefanie Aust et al.
PLOS ONE (2015)
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index
Younak Choi et al.
PLOS ONE (2015)
Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
Madoka Kimura et al.
SUPPORTIVE CARE IN CANCER (2015)
Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy
Michael P. Chu et al.
PLOS ONE (2015)
Measurement of skeletal muscle radiation attenuation and basis of its biological variation
J. Aubrey et al.
ACTA PHYSIOLOGICA (2014)
Matched Pair Analysis to Examine the Effects of a Planned Preoperative Exercise Program in Early Gastric Cancer Patients with Metabolic Syndrome to Reduce Operative Risk: The Adjuvant Exercise for General Elective Surgery (AEGES) Study Group
Haruhiko Cho et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer
Carla M. M. Prado et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2014)
Sarcopenia in Patients With Bladder Cancer Undergoing Radical Cystectomy Impact on Cancer-Specific and All-Cause Mortality
Sarah P. Psutka et al.
CANCER (2014)
Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer
Connie Yip et al.
EUROPEAN RADIOLOGY (2014)
Low skeletal muscle is associated with toxicity in patients included in phase I trials
Sophie Cousin et al.
INVESTIGATIONAL NEW DRUGS (2014)
Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention
Carla M. M. Prado et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2014)
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Liang-Kung Chen et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2014)
Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Helene Lanic et al.
LEUKEMIA & LYMPHOMA (2014)
Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer
Maximilien Barret et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2014)
Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis
D. Santa Mina et al.
PHYSIOTHERAPY (2014)
Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?
David R. Fogelman et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)
Cancer cachexia: understanding the molecular basis
Josep M. Argiles et al.
NATURE REVIEWS CANCER (2014)
Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review
Tora S. Solheim et al.
ACTA ONCOLOGICA (2013)
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
Carla M. Prado et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer
C. Pezaro et al.
BRITISH JOURNAL OF CANCER (2013)
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
O. Huillard et al.
BRITISH JOURNAL OF CANCER (2013)
Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia
Katie M. Di Sebastiano et al.
BRITISH JOURNAL OF NUTRITION (2013)
Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma
N. Harimoto et al.
BRITISH JOURNAL OF SURGERY (2013)
Sarcopenia and Physical Function In Overweight Patients with Advanced Cancer
Carla M. M. Prado et al.
CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH (2013)
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies
Sami Antoun et al.
CANCER (2013)
Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results
Lene Thoresen et al.
CLINICAL NUTRITION (2013)
Effect of physical exercise on muscle mass and strength in cancer patients during treatment-A systematic review
G. B. Stene et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Body composition and survival in the early clinical trials setting
H. Veasey Rodrigues et al.
EUROPEAN JOURNAL OF CANCER (2013)
Body Composition Variation and Impact of Low Skeletal Muscle Mass in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib: Results From a Placebo-Controlled Study
Marie-Helene Massicotte et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma
Judith Meza-Junco et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A pilot study of temsirolimus and body composition
Heloisa Veasey-Rodrigues et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2013)
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer
Sami Antoun et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2013)
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma
C. M. M. Prado et al.
BRITISH JOURNAL OF CANCER (2012)
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery
J. R. Lieffers et al.
BRITISH JOURNAL OF CANCER (2012)
Body composition and outcome in patients undergoing resection of colorectal liver metastases
M. G. van Vledder et al.
BRITISH JOURNAL OF SURGERY (2012)
Dietary Patterns of Patients: With Advanced Lung or Colorectal Cancer
Carla M. M. Prado et al.
CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH (2012)
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
Sherif Awad et al.
CLINICAL NUTRITION (2012)
The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma
L. Thoresen et al.
EUROPEAN JOURNAL OF CANCER CARE (2012)
Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT
B. S. van der Meij et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2012)
Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
Peter Peng et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Relationships Among Body Mass Index, Longitudinal Body Composition Alterations, and Survival in Patients With Locally Advanced Pancreatic Cancer Receiving Chemoradiation: A Pilot Study
Shalini Dalal et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2012)
Oral Nutritional Interventions in Malnourished Patients With Cancer: A Systematic Review and Meta-Analysis
Christine Baldwin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Evaluation of the Clinical Relevance of Body Composition Parameters in Patients With Cancer Metastatic to the Liver Treated With Hepatic Arterial Infusion Chemotherapy
Henrique A. Parsons et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
Fish Oil Supplement Alters Markers of Inflammatory and Nutritional Status in Colorectal Cancer Patients
Juliana de Aguiar Pastore Silva et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
The Relationship Between Body Composition and Response to Neoadjuvant Chemotherapy in Women with Operable Breast Cancer
Egidio Del Fabbro et al.
ONCOLOGIST (2012)
A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPCRC cachexia guidelines project
Anke Ries et al.
PALLIATIVE MEDICINE (2012)
Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma
Olivier Mir et al.
PLOS ONE (2012)
Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
Michael S. Sabel et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Nutritional Intervention With Fish Oil Provides a Benefit Over Standard of Care for Weight and Skeletal Muscle Mass in Patients With Nonsmall Cell Lung Cancer Receiving Chemotherapy
Rachel A. Murphy et al.
CANCER (2011)
An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity
Carla M. M. Prado et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia
Roger A. Fielding et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis
Peter D. Peng et al.
HPB (2011)
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz-Jentoft et al.
AGE AND AGEING (2010)
Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
Vickie E. Baracos et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
S. Antoun et al.
ANNALS OF ONCOLOGY (2010)
Association of Skeletal Muscle Wasting With Treatment With Sorafenib in Patients With Advanced Renal Cell Carcinoma: Results From a Placebo-Controlled Study
Sami Antoun et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Skeletal Muscle Depletion Is Associated with Reduced Plasma (n-3) Fatty Acids in Non-Small Cell Lung Cancer Patients
Rachel A. Murphy et al.
JOURNAL OF NUTRITION (2010)
Skeletal muscle fat infiltration: Impact of age, inactivity, and exercise
R. L. Marcus et al.
JOURNAL OF NUTRITION HEALTH & AGING (2010)
A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands
Jessica R. Lieffers et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) Preserves Lean Body Mass Following Esophageal Cancer Surgery: Results of a Double-Blinded Randomized Controlled Trial
Aoife M. Ryan et al.
ANNALS OF SURGERY (2009)
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Benjamin H. L. Tan et al.
CLINICAL CANCER RESEARCH (2009)
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2009)
Anorexia-Cachexia Syndrome: A Systematic Review of the Role of Dietary Polyunsaturated Fatty Acids in the Management of Symptoms, Survival, and Quality of Life
Paolo Mazzotta et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
Marina Mourtzakis et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2008)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity
Carla M. M. Prado et al.
CLINICAL CANCER RESEARCH (2007)
The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study
Bret H. Goodpaster et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)
Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia
Kenneth C. H. Fearon et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
W Shen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort
A Jatoi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Dosing strategies for anticancer drugs: the good, the bad and body-surface area
A Felici et al.
EUROPEAN JOURNAL OF CANCER (2002)
Share Paper
